The Essential Role of the Aromatase/P450arom

Udo Meinhardt; Primus E. Mullis

doi:10.1055/s-2002-35374

Seminars in Reproductive Medicine, Table of Contents

Semin Reprod Med 2002; 20(3): 277-284
DOI: 10.1055/s-2002-35374

The Essential Role of the Aromatase/P450arom

Udo Meinhardt, Primus E. Mullis

Department of Pediatrics, Pediatric Endocrinology/Diabetology and Metabolism, University Children's Hospital, Inselspital, Bern, Switzerland

Abstract

ABSTRACT

Aromatase (P450arom) catalyzes the conversion of testosterone to estradiol, androstenedione to estrone, and 16a-hydroxylated dehydroepiandrosterone to estriol. P450arom is encoded by the human CYP19 gene (15q21.1) spanning about 123 kb with a coding region of 9 exons (about 30 kb, exon II to exon X). Although there are a number of alternative first exons and nine different transcriptional start sides with individual promoters that permit tissue-specific regulation of expression, the protein expressed in these various tissue sites (placenta, adipose tissue, brain, bone, ovary, etc.) always remains the same. As not only androgens but also estrogens are of importance particularly in male pubertal development including bone changes, which were classically considered androgen dependent, the features of the aromatase deficiency syndrome in affected boys and girls as well as adult males and females are discussed. There is growing awareness that androgens and estrogens have general metabolic roles that reach far beyond reproductive processes. For instance, estrogen has a significant impact on carbohydrate and lipid metabolism, vascular function, and arteriosclerosis. In addition, extragonadal estrogen biosynthesis plays an important but often underestimated physiological and pathophysiological role, for example, in breast cancer and endometriosis. Based on that knowledge, progress has been made as far as treatment and follow-up of this disorder are concerned.

KEYWORDS

Aromatase - aromatase deficiency - P450arom - pseudohermaphroditism - virilization

Full Text

References

REFERENCES

1 Nelson D R, Koymans L, Kamataki T. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics . 1996; 6 1-42
2 Simpson E R, Mahendroo M S, Means G D. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev . 1994; 15 342-355
3 Shimozawa O, Sakaguchi M, Ogawa H. Core glycosylation of cytochrome P-450(arom): evidence for localization of N terminus of microsomal cytochrome P-450 in the lumen. J Biol Chem . 1993; 268 21399-21402
4 Simpson E R, Mahendroo M S, Means G D. Tissue-specific promoters regulate aromatase cytochrome P450 expression. J Steroid Biochem Mol Biol . 1993; 44 321-330
5 Simpson E R, Davis S R. Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology . 2001; 142 4589-4594
6 Sebastian S, Bulun S E. Genetics of endocrine disease, a highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project. J Clin Endocrinol Metab . 2001; 86 4600-4602
7 Thornton J W. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansion. Proc Natl Acad Sci U S A . 2001; 98 5671-5676
8 Grumbach M M, Auchus R J. Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab . 1999; 84 4677-4694
9 Fisher C R, Graves K H, Parlow A F, Simpson E R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A . 1998; 95 6965-69770
10 Deladoëy J, Flück C, Bex M. Aromatase deficiency caused by a novel P450arom gene mutation: impact of absent estrogen production on serum gonadotropin concentration in a boy. J Clin Endocrinol Metab . 1999; 84 4050-4054
11 Mullis P E, Yoshimura N, Kuhlmann B. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab . 1997; 82 1739-1745
12 Conte F A, Grumbach M M, Ito Y, Fisher C R, Simpson E R. A syndrome of female pseudohermaphroditism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450arom). J Clin Endocrinol Metab . 1994; 78 1287-1792
13 Ito Y, Fisher C R, Conte F A, Grumbach M M, Simpson E R. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A . 1993; 90 11673-11677
14 Aittomäki K, Herva R, Stenman U-H. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab . 1996; 81 3722-3726
15 Simpson E R, Zhao Y, Argawal V R. Aromatase expression in health and disease. Recent Prog Horm Res . 1997; 52 185-213
16 MacDonald P C, Madden J D, Brenner P F. Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab . 1979; 49 905-916
17 Skinner M K. Cell-cell interactions in the testis. Endocr Rev . 1991; 12 45-77
18 Santen R J. Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men?. J Clin Invest . 1975; 56 1555-1563
19 Bicsak T A, Vale W, Vaughan J. Hormonal regulation of inhibin production by cultures Sertoli cells. Mol Cell Endocrinol . 1987; 49 211-217
20 Oerter Klein K, Baron J, Colli M J, McDonnell D P, Cutler G B. Estrogen levels in childhood determined by an ultrasensitive recombinant bioassay. J Clin Invest . 1994; 94 2475-2480
21 Andersson A M, Toppari J, Haavisto A M. Longitudinal reproductive profiles in infants: peak of inhibin B levels in infant boys exceed levels of adult men. J Clin Endocrinol Metab . 1998; 83 675-681
22 Bilezikan J P, Morishima A, Bell J, Grumbach M M. Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med . 1998; 339 599-603
23 Carani C, Qin K, Simoni M. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med . 1997; 337 91-95
24 Rochira V, Faustini-Fustini M, Balestrieri A, Carani C. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters. J Clin Endocrinol Metab . 2000; 85 1841-1845
25 Bulun S E. Clinical review 78-aromatase deficiency in woman and men: would you have predicted the phenotypes?. J Clin Endocrinol Metab . 1996; 81 867-871
26 Bhatnagar A S, Muller P, Schenkel L. Inhibition of estrogen biosynthesis and its consequences on gonadotropin secretion in the male. J Steroid Biochem Mol Biol . 1992; 41 437-443
27 Klein K O, Martha Jr M P, Blizzard R M, Herbst T, Rogol A D. A longitudinal assessment of hormonal and physical alterations during normal puberty in boys: II. Estrogen levels as determined by an ultrasensitive bioassay. J Clin Endocrinol Metab . 1996; 81 3203-3207
28 Zachmann M, Prader A, Sobel E H. Pubertal growth in patients with androgen insensitivity: indirect evidence for the importance of estrogen in pubertal growth of girls. J Pediatr . 1986; 108 694-697
29 Stratakis C A, Vottero A, Brodie A. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab . 1998; 83 1348-1357
30 Morishima A, Grumbach M M, Simpson E R, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab . 1995; 80 3689-3698
31 Mendelsohn M E, Karas R H. The protective effects of estrogen on the cardiovascular system. N Engl J Med . 1999; 340 1801-1811
32 Sudhir K, Komesaroff P A. Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab . 1999; 84 3411-3414
33 Pasqualini J R, Chetrite G, Blacker C. Concentrations of estrone, and estradiol, estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab . 1996; 81 1460-1464
34 Castagnetta L A, Lo Casto M, Granata O M. Estrogen content and metabolism in human breast tumour tissue and cells. Ann N Y Acad Sci . 1996; 784 314-324
35 Bulun S E, Zeitoun K M, Takayama K, Simpson E R, Sasano H. Aromatase as a therapeutic target in endometriosis. Trends Endocrinol Metab . 2000; 11 22-27
36 Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab . 1991; 72 560-566
37 Harada N, Ogawa H, Shozu M. Genetic studies to characterize the origin of the mutation in placental aromatase deficiency. Am J Hum Genet . 1992; 51 666-672
38 Portrat-Doyen S, Forest M G, Nicolino M, Morel Y, Chatelain P C. Female pseudohermaphroditism (FPH) resulting from aromatase (p450arom) deficiency associated with a novel mutation (R457) in the CYP19 gene. Horm Res . 1996; 46(suppl) 14
39 Ludwig M, Beck A, Wickert L. Female pseudohermaphroditism associated with a novel homozygous G-to-A (V370-toM) substitution in the P-450 aromatase gene. J Pediatr Endocrinol Metab . 1998; 11 657-664